Edgewise Therapeutics Q3 Adj. EPS $(0.19) Misses $2.48 Estimate
Benzinga Newsdesk 1 day ago
NewsEarningsEarnings Misses
Edgewise Therapeutics (NASDAQ:EWTX) reported quarterly losses of $(0.19) per share which missed the analyst consensus estimate of $2.48 by 107.66 percent. This is a 51.28 percent increase over losses of $(0.39) per
Edgewise Therapeutics (NASDAQ:EWTX) reported quarterly losses of $(0.19) per share which missed the analyst consensus estimate of $2.48 by 107.66 percent. This is a 51.28 percent increase over losses of $(0.39) per share from the same period last year.